SCOPUS 정보 검색 플랫폼

Archives of Pharmacal Research

Volumn 34, Issue 11, 2011, Pages 1865-1877

Role of transporters in drug interactions

(1) Han, Hyo Kyung a

a Dongguk University (South Korea)

Author keywords

ADME; Drug interaction; Efflux; Transporter; Uptake

Indexed keywords

ABACAVIR; AMPRENAVIR; ATAZANAVIR; ATORVASTATIN; CARRIER PROTEIN; CYCLOSPORIN; CYTOCHROME P450; DARUNAVIR; DIGOXIN; EFAVIRENZ; FEXOFENADINE; FOSAMPRENAVIR; GLYCOPROTEIN P; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; ITRACONAZOLE; LOPINAVIR; NIFEDIPINE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; RIFAMPICIN; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; TALINOLOL; TENOFOVIR DISOPROXIL; TIPRANAVIR; UNINDEXED DRUG; VALSPODAR; VERAPAMIL;

BINDING AFFINITY; DRUG APPROVAL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTERACTION; DRUG METABOLISM; DRUG SAFETY; DRUG TARGETING; DRUG TRANSPORT; ENZYME SPECIFICITY; FOOD DRUG INTERACTION; HERB DRUG INTERACTION; HUMAN; KIDNEY CLEARANCE; METABOLIC CLEARANCE RATE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; SINGLE DRUG DOSE; TOXICOKINETICS;

ANIMALS; BIOLOGICAL TRANSPORT; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; GENE EXPRESSION REGULATION; HERB-DRUG INTERACTIONS; HUMANS; INTESTINES; KIDNEY; LIVER; ORGANIC ANION TRANSPORTERS; P-GLYCOPROTEIN; PHARMACOKINETICS; PLANT PREPARATIONS;

EID: 83655197410 PISSN: 02536269 EISSN: 19763786 Source Type: Journal
DOI: 10.1007/s12272-011-1107-y Document Type: Review

Times cited : (43)

References (111)

1
- 0023836456
- Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog
- S. Akiyama M. M. Cornwell M. Kuwano I. Pastan M. M. Gottesman 1988 Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog Mol. Pharmacol. 33 144 147 2893251 1:CAS:528:DyaL1cXhs1WjsLw%3D (Pubitemid 18068120)
- (1988) Molecular Pharmacology , vol.33 , Issue.2 , pp. 144-147
- Akiyama, S.-I.¹ Cornwell, M.M.² Kuwano, M.³ Pastan, I.⁴ Gottesman, M.M.⁵

2
- 0344825356
- P-glycoprotein: From genomics to mechanism
- DOI 10.1038/sj.onc.1206948, Drug Resistance
- S. V. Ambudkar C. Kimchi-Sarfaty Z. E. Sauna M. M. Gottesman 2003 P-glycoprotein: from genomics to mechanism Oncogene 22 7468 7485 14576852 1:CAS:528:DC%2BD3sXotlaju70%3D 10.1038/sj.onc.1206948 (Pubitemid 37487170)
- (2003) Oncogene , vol.22 , Issue.47 , pp. 7468-7485
- Ambudkar, S.V.¹ Kimchi-Sarfaty, C.² Sauna, Z.E.³ Gottesman, M.M.⁴

3
- 77955994141
- Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin
- 20519340 1:CAS:528:DC%2BC3cXhtFegu73M 10.1124/dmd.110.032268
- R. Amundsen H. Christensen B. Zabihyan A. Asberg 2010 Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin Drug Metab. Dispos. 38 1499 1504 20519340 1:CAS:528:DC%2BC3cXhtFegu73M 10.1124/dmd.110.032268
- (2010) Drug Metab. Dispos. , vol.38 , pp. 1499-1504
- Amundsen, R.¹ Christensen, H.² Zabihyan, B.³ Asberg, A.⁴

4
- 77149153424
- Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1
- 20102298 1:CAS:528:DC%2BC3cXhslKqs7k%3D 10.3109/00498250903509375
- P. Annaert Z. W. Ye B. Stieger P. Augustijns 2010 Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1 Xenobiotica 40 163 176 20102298 1:CAS:528:DC%2BC3cXhslKqs7k%3D 10.3109/00498250903509375
- (2010) Xenobiotica , vol.40 , pp. 163-176
- Annaert, P.¹ Ye, Z.W.² Stieger, B.³ Augustijns, P.⁴

5
- 33745953360
- Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants
- DOI 10.1124/jpet.106.104364
- I. Badagnani R. A. Castro T. R. Taylor C. M. Brett C. C. Huang D. Stryke M. Kawamoto S. J. Johns T. E. Ferrin E. J. Carlson E. G. Burchard K. M. Giacomini 2006 Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants J. Pharmacol. Exp. Ther. 318 521 529 16702441 1:CAS:528:DC%2BD28XnslOls7g%3D 10.1124/jpet.106.104364 (Pubitemid 44061225)
- (2006) Journal of Pharmacology and Experimental Therapeutics , vol.318 , Issue.2 , pp. 521-529
- Badagnani, I.¹ Castro, R.A.² Taylor, T.R.³ Brett, C.M.⁴ Huang, C.C.⁵ Stryke, D.⁶ Kawamoto, M.⁷ Johns, S.J.⁸ Ferrin, T.E.⁹ Carlson, E.J.¹⁰ Burchard, E.G.¹¹ Giacomini, K.M.¹²

6
- 33947420519
- Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice
- DOI 10.1038/sj.clpt.6100104, PII 6100104
- D. G. Bailey G. K. Dresser B. F. Leake R. B. Kim 2007 Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice Clin. Pharmacol. Ther. 81 495 502 17301733 1:CAS:528:DC%2BD2sXkvFymu74%3D 10.1038/sj.clpt.6100104 (Pubitemid 46452308)
- (2007) Clinical Pharmacology and Therapeutics , vol.81 , Issue.4 , pp. 495-502
- Bailey, D.G.¹ Dresser, G.K.² Leake, B.F.³ Kim, R.B.⁴

7
- 78649308647
- Fruit juice inhibition of uptake transport: A new type of food-drug interaction
- 21039758 1:CAS:528:DC%2BC3cXhsFWhu7zO 10.1111/j.1365-2125.2010.03722.x
- D. G. Bailey 2010 Fruit juice inhibition of uptake transport: a new type of food-drug interaction Br. J. Clin. Pharmacol. 70 645 655 21039758 1:CAS:528:DC%2BC3cXhsFWhu7zO 10.1111/j.1365-2125.2010.03722.x
- (2010) Br. J. Clin. Pharmacol. , vol.70 , pp. 645-655
- Bailey, D.G.¹

8
- 0019945650
- The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor
- M. Barza A. Kane J. Baum 1982 The effects of infection and probenecid on the transport of carbenicillin from the rabbit vitreous humor Invest. Ophthalmol. Vis. Sci. 22 720 726 7076417 1:CAS:528:DyaL38Xks1Gqtrc%3D (Pubitemid 12051299)
- (1982) Investigative Ophthalmology and Visual Science , vol.22 , Issue.6 , pp. 720-726
- Barza, M.¹ Kane, A.² Baum, J.³

9
- 0042318871
- CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide
- DOI 10.1046/j.0306-5251.2003.01862.x
- T. B. Bidstrup I. Bjørnsdottir U. G. Sidelmann M. S. Thomsen K. T. Hansen 2003 CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide Br. J. Clin. Pharmacol. 56 305 314 12919179 1:CAS:528:DC%2BD3sXnvVSgurs%3D 10.1046/j.0306-5251.2003.01862.x (Pubitemid 37059658)
- (2003) British Journal of Clinical Pharmacology , vol.56 , Issue.3 , pp. 305-314
- Bidstrup, T.B.¹ Bjornsdottir, I.² Sidelmann, U.G.³ Thomsen, M.S.⁴ Hansen, K.T.⁵

10
- 2442455598
- Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide
- DOI 10.1007/s00228-004-0746-z
- T. B. Bidstrup N. Stilling P. Damkier B. Scharling M. S. Thomsen K. Brøsen 2004 Rifampicin seems to act as both an inducer and an inhibitor of the metabolism of repaglinide Eur. J. Clin. Pharmacol. 60 109 114 15034704 1:CAS:528:DC%2BD2cXjtFyit7g%3D 10.1007/s00228-004-0746-z (Pubitemid 38626440)
- (2004) European Journal of Clinical Pharmacology , vol.60 , Issue.2 , pp. 109-114
- Bidstrup, T.B.¹ Stilling, N.² Damkier, P.³ Scharling, B.⁴ Thomsen, M.S.⁵ Brosen, K.⁶

11
- 0033997593
- Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A
- DOI 10.1046/j.1523-1755.2000.00838.x
- I. Binet A. Wallnöfer C. Weber R. Jones G. Thiel 2000 Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A Kidney Int. 57 224 231 10620203 1:CAS:528:DC%2BD3cXivFOlu7g%3D 10.1046/j.1523-1755.2000.00838.x (Pubitemid 30227769)
- (2000) Kidney International , vol.57 , Issue.1 , pp. 224-231
- Binet, I.¹ Wallnofer, A.² Weber, C.³ Jones, R.⁴ Thiel, G.⁵

12
- 0242538618
- Herbs continue slide in mainstream market: Sales down 14%
- M. Blumenthal 2003 Herbs continue slide in mainstream market: sales down 14% HerbalGram 58 71
- (2003) HerbalGram , vol.58 , pp. 71
- Blumenthal, M.¹

13
- 0037370996
- Transport of cimetidine by flounder and human renal organic anion transporter 1
- 12429554 1:CAS:528:DC%2BD3sXisFemsb4%3D
- B. C. Burckhardt S. Brai S. Wallis W. Krick N. A. Wolff G. Burckhardt 2003 Transport of cimetidine by flounder and human renal organic anion transporter 1 Am. J. Physiol. Renal. Physiol. 284 F503 F509 12429554 1:CAS:528:DC%2BD3sXisFemsb4%3D
- (2003) Am. J. Physiol. Renal. Physiol. , vol.284
- Burckhardt, B.C.¹ Brai, S.² Wallis, S.³ Krick, W.⁴ Wolff, N.A.⁵ Burckhardt, G.⁶

14
- 78649665012
- In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy
- 21103968 1:CAS:528:DC%2BC3MXmsFWrsrg%3D 10.1007/978-3-642-14541-4-2
- G. Burckhardt B. C. Burckhardt 2011 In vitro and in vivo evidence of the importance of organic anion transporters (OATs) in drug therapy Handb. Exp. Pharmacol. 201 29 104 21103968 1:CAS:528:DC%2BC3MXmsFWrsrg%3D 10.1007/978-3-642-14541-4-2
- (2011) Handb. Exp. Pharmacol. , vol.201 , pp. 29-104
- Burckhardt, G.¹ Burckhardt, B.C.²

15
- 43649084621
- Potential of pharmacokinetic profiling for detecting herbal interactions with drugs
- DOI 10.2165/00003088-200847060-00003
- V. Butterweck H. Derendorf 2008 Potential of pharmacokinetic profiling for detecting herbal interactions with drugs Clin. Pharmacokinet. 47 383 397 18479173 1:CAS:528:DC%2BD1cXos1ehsro%3D 10.2165/00003088-200847060-00003 (Pubitemid 351685388)
- (2008) Clinical Pharmacokinetics , vol.47 , Issue.6 , pp. 383-397
- Butterweck, V.¹ Derendorf, H.²

16
- 33644829720
- Drug-associated renal dysfunction and injury
- DOI 10.1038/ncpneph0076, PII N0076
- D. Choudhury Z. Ahmed 2006 Drug-associated renal dysfunction and injury Nat. Clin. Pract. Nephrol. 2 80 91 16932399 1:CAS:528:DC%2BD28XmvV2nt7Y%3D 10.1038/ncpneph0076 (Pubitemid 43355216)
- (2006) Nature Clinical Practice Nephrology , vol.2 , Issue.2 , pp. 80-91
- Choudhury, D.¹ Ahmed, Z.²

17
- 0032997095
- Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir
- K. C. Cundy 1999 Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir Clin. Pharmacokinet. 36 127 143 10092959 1:CAS:528:DyaK1MXitFCntLs%3D 10.2165/00003088-199936020-00004 (Pubitemid 29121686)
- (1999) Clinical Pharmacokinetics , vol.36 , Issue.2 , pp. 127-143
- Cundy, K.C.¹

18
- 3042568988
- Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers
- DOI 10.1016/j.clpt.2004.02.008, PII S0009923604000700
- R. Ding Y. Tayrouz K. D. Riedel J. Burhenne J. Weiss G. Mikus W. E. Haefeli 2004 Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers Clin. Pharmacol. Ther. 76 73 84 15229466 1:CAS:528:DC%2BD2cXlsVaqtrc%3D 10.1016/j.clpt.2004.02.008 (Pubitemid 38844736)
- (2004) Clinical Pharmacology and Therapeutics , vol.76 , Issue.1 , pp. 73-84
- Ding, R.¹ Tayrouz, Y.² Riedel, K.-D.³ Burhenne, J.⁴ Weiss, J.⁵ Mikus, G.⁶ Haefeli, W.E.⁷

19
- 34748887980
- Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: Implications for predicting clinical drug interactions
- DOI 10.1124/dmd.107.016089
- V. Dixit N. Hariparsad F. Li P. Desai K. E. Thummel J. D. Unadkat 2007 Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions Drug Metab. Dispos. 35 1853 1859 17639026 1:CAS:528:DC%2BD2sXhtFansbbL 10.1124/dmd.107.016089 (Pubitemid 47481578)
- (2007) Drug Metabolism and Disposition , vol.35 , Issue.10 , pp. 1853-1859
- Dixit, V.¹ Hariparsad, N.² Li, F.³ Desai, P.⁴ Thummel, K.E.⁵ Unadkat, J.D.⁶

20
- 0023922967
- Digoxin-cyclosporine interaction: Severe digitalis toxicity after cyclosporine treatment
- 3396255 1:STN:280:DyaL1c3ot12ntA%3D%3D
- P. Dorian M. Strauss C. Cardella T. David S. East R. Ogilvie 1988 Digoxin-cyclosporine interaction: severe digitalis toxicity after cyclosporine treatment Clin. Invest. Med. 11 108 112 3396255 1:STN:280:DyaL1c3ot12ntA%3D%3D
- (1988) Clin. Invest. Med. , vol.11 , pp. 108-112
- Dorian, P.¹ Strauss, M.² Cardella, C.³ David, T.⁴ East, S.⁵ Ogilvie, R.⁶

21
- 0036159433
- Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
- DOI 10.1067/mcp.2002.121152
- G. K. Dresser D. G. Bailey B. F. Leake U. I. Schwarz P. A. Dawson D. J. Freeman R. B. Kim 2002 Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine Clin. Pharmacol. Ther. 71 11 20 11823753 1:CAS:528: DC%2BD38XitFOgs7c%3D 10.1067/mcp.2002.121152 (Pubitemid 34124034)
- (2002) Clinical Pharmacology and Therapeutics , vol.71 , Issue.1 , pp. 11-20
- Dresser, G.K.¹ Bailey, D.G.² Leake, B.F.³ Schwarz, U.I.⁴ Dawson, P.A.⁵ Freeman, D.J.⁶ Kim, R.B.⁷

22
- 13944275994
- Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: Possible role of organic anion transporting polypeptides
- DOI 10.1016/j.clpt.2004.10.005
- G. K. Dresser R. B. Kim D. G. Bailey 2005 Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides Clin. Pharmacol. Ther. 77 170 177 15735611 1:CAS:528:DC%2BD2MXhsVyrs78%3D 10.1016/j.clpt.2004.10.005 (Pubitemid 40269132)
- (2005) Clinical Pharmacology and Therapeutics , vol.77 , Issue.3 , pp. 170-177
- Dresser, G.K.¹ Kim, R.B.² Bailey, D.G.³

23
- 0141615878
- Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone
- DOI 10.1093/rheumatology/keg277
- R. I. Fox S. L. Morgan H. T. Smith B. A. Robbins M. G. Choc J. E. Baggott 2003 Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone Rheumatology (Oxford) 42 989 994 1:CAS:528:DC%2BD3sXlsl2ltbo%3D 10.1093/rheumatology/keg277 (Pubitemid 37220969)
- (2003) Rheumatology , vol.42 , Issue.8 , pp. 989-994
- Fox, R.I.¹ Morgan, S.L.² Smith, H.T.³ Robbins, B.A.⁴ Choc, M.G.⁵ Baggott, J.E.⁶

24
- 84954358022
- The solute carrier (SLC) complement of the human genome: Phylogenetic classification reveals four major families
- 18948099 1:CAS:528:DC%2BD1cXhtlaqtrnN 10.1016/j.febslet.2008.10.016
- R. Fredriksson K. J. Nordström O. Stephansson M. G. Hägglund H. B. Schiöth 2008 The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families FEBS Lett. 582 3811 3816 18948099 1:CAS:528:DC%2BD1cXhtlaqtrnN 10.1016/j.febslet.2008.10.016
- (2008) FEBS Lett. , vol.582 , pp. 3811-3816
- Fredriksson, R.¹ Nordström, K.J.² Stephansson, O.³ Hägglund, M.G.⁴ Schiöth, H.B.⁵

25
- 29144436223
- Membrane transporters and drug response
- L. L. Brunton J. S. Lazo K. L. Parker (eds). McGraw-Hill New York
- Giacomini, K. M. and Sugiyama, Y., Membrane transporters and drug response. In Brunton, L. L., Lazo, J. S., and Parker, K. L. (Eds.). Goodman & Gilman's the Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp. 41-70, (2006).
- (2006) Goodman & Gilman's the Pharmacological Basis of Therapeutics , pp. 41-70
- Giacomini, K.M.¹ Sugiyama, Y.²

26
- 77649216536
- Membrane transporters in drug development
- 20190787 1:CAS:528:DC%2BC3cXisFelu74%3D 10.1038/nrd3028
- K. M. Giacomini S. M. Huang D. J. Tweedie L. Z. Benet K. L. Brouwer X. Chu A. Dahlin R. Evers V. Fischer K. M. Hillgren K. A. Hoffmaster T. Ishikawa D. Keppler R. B. Kim C. A. Lee M. Niemi J. W. Polli Y. Sugiyama P. W. Swaan J. A. Ware S. H. Wright S. W. Yee M. J. Zamek-Gliszczynski L. Zhang 2010 Membrane transporters in drug development Nat. Rev. Drug Discov. 9 215 236 20190787 1:CAS:528:DC%2BC3cXisFelu74%3D 10.1038/nrd3028
- (2010) Nat. Rev. Drug Discov. , vol.9 , pp. 215-236
- Giacomini, K.M.¹ Huang, S.M.² Tweedie, D.J.³ Benet, L.Z.⁴ Brouwer, K.L.⁵ Chu, X.⁶ Dahlin, A.⁷ Evers, R.⁸ Fischer, V.⁹ Hillgren, K.M.¹⁰ Hoffmaster, K.A.¹¹ Ishikawa, T.¹² Keppler, D.¹³ Kim, R.B.¹⁴ Lee, C.A.¹⁵ Niemi, M.¹⁶ Polli, J.W.¹⁷ Sugiyama, Y.¹⁸ Swaan, P.W.¹⁹ Ware, J.A.²⁰ more..

27
- 0032754284
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
- 10411543 1:CAS:528:DyaK1MXkslSmsb8%3D 10.1172/JCI6663
- B. Greiner M. Eichelbaum P. Fritz H. P. Kreichgauer O. von Richter J. Zundler H. K. Kroemer 1999 The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin J. Clin. Invest. 104 147 153 10411543 1:CAS:528:DyaK1MXkslSmsb8%3D 10.1172/JCI6663
- (1999) J. Clin. Invest. , vol.104 , pp. 147-153
- Greiner, B.¹ Eichelbaum, M.² Fritz, P.³ Kreichgauer, H.P.⁴ Von Richter, O.⁵ Zundler, J.⁶ Kroemer, H.K.⁷

28
- 0037427972
- The superfamily of organic anion transporting polypeptides
- DOI 10.1016/S0005-2736(02)00633-8, PII S0005273602006338
- B. Hagenbuch P. J. Meier 2003 The superfamily of organic anion transporting polypeptides Biochim. Biophys. Acta 1609 1 18 12507753 1:CAS:528:DC%2BD38XpvVais7g%3D 10.1016/S0005-2736(02)00633-8 (Pubitemid 36044060)
- (2003) Biochimica et Biophysica Acta - Biomembranes , vol.1609 , Issue.1 , pp. 1-18
- Hagenbuch, B.¹ Meier, P.J.²

29
- 0035107449
- The effect of rifampin administration on the disposition of fexofenadine
- DOI 10.1067/mcp.2001.113697
- M. A. Hamman M. A. Bruce B. D. Haehner-Daniels S. D. Hall 2001 The effect of rifampin administration on the disposition of fexofenadine Clin. Pharmacol. Ther. 69 114 121 11240975 1:CAS:528:DC%2BD3MXislylsLk%3D 10.1067/mcp.2001.113697 (Pubitemid 32225411)
- (2001) Clinical Pharmacology and Therapeutics , vol.69 , Issue.3 , pp. 114-121
- Hamman, M.A.¹ Bruce, M.A.² Haehner-Daniels, B.D.³ Hall, S.D.⁴

30
- 1242340323
- The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins
- DOI 10.1007/s00424-003-1192-y, The ABCs of Solute Carriers: Physiological, Pathological and Therapeutic Implications of Human Membrane Transport Proteins
- M. A. Hediger M. F. Romero J. B. Peng A. Rolfs H. Takanaga E. A. Bruford 2004 The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins Pflugers Arch. 447 465 468 14624363 1:CAS:528:DC%2BD2cXhtVygt70%3D 10.1007/s00424-003-1192-y (Pubitemid 38241432)
- (2004) Pflugers Archiv European Journal of Physiology , vol.447 , Issue.5 , pp. 465-468
- Hediger, M.A.¹ Romero, M.F.² Peng, J.-B.³ Rolfs, A.⁴ Takanaga, H.⁵ Bruford, E.A.⁶

31
- 0036007742
- St. John's Wort increases expression of P-glycoprotein: Implications for drug interactions
- DOI 10.1046/j.0306-5251.2001.01516.x
- M. Hennessy D. Kelleher J. P. Spiers M. Barry P. Kavanagh D. Back F. Mulcahy J. Feely 2002 St Johns wort increases expression of P-glycoprotein: implications for drug interactions Br. J. Clin. Pharmacol. 53 75 82 11849198 1:CAS:528:DC%2BD38XhtFWrs7k%3D 10.1046/j.0306-5251.2001.01516.x (Pubitemid 34117742)
- (2002) British Journal of Clinical Pharmacology , vol.53 , Issue.1 , pp. 75-82
- Hennessy, M.¹ Kelleher, D.² Spiers, J.P.³ Barry, M.⁴ Kavanagh, P.⁵ Back, O.⁶ Mulcahy, F.⁷ Feely, J.⁸

32
- 34547169521
- Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines
- DOI 10.1124/dmd.107.014902
- C. Hilgendorf G. Ahlin A. Seithel P. Artursson A. L. Ungell J. Karlsson 2007 Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines Drug Metab. Dispos. 35 1333 1340 17496207 1:CAS:528:DC%2BD2sXosVKqtbg%3D 10.1124/dmd.107.014902 (Pubitemid 47121774)
- (2007) Drug Metabolism and Disposition , vol.35 , Issue.8 , pp. 1333-1340
- Hilgendorf, C.¹ Ahlin, G.² Seithel, A.³ Artursson, P.⁴ Ungell, A.-L.⁵ Karlsson, J.⁶

33
- 33745243715
- Drugdrug interaction between pitavastatin and various drugs via OATP1B1
- 16595711 1:CAS:528:DC%2BD28XmsVKqsb4%3D 10.1124/dmd.106.009290
- M. Hirano K. Maeda Y. Shitara Y. Sugiyama 2006 Drugdrug interaction between pitavastatin and various drugs via OATP1B1 Drug Metab. Dispos. 34 1229 1236 16595711 1:CAS:528:DC%2BD28XmsVKqsb4%3D 10.1124/dmd.106.009290
- (2006) Drug Metab. Dispos. , vol.34 , pp. 1229-1236
- Hirano, M.¹ Maeda, K.² Shitara, Y.³ Sugiyama, Y.⁴

34
- 0032919287
- Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney
- 9887087 1:CAS:528:DyaK1MXntlCntA%3D%3D
- M. Hosoyamada T. Sekine Y. Kanai H. Endou 1999 Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney Am. J. Physiol. 276 F122 F128 9887087 1:CAS:528:DyaK1MXntlCntA%3D%3D
- (1999) Am. J. Physiol. , vol.276
- Hosoyamada, M.¹ Sekine, T.² Kanai, Y.³ Endou, H.⁴

35
- 49649092002
- Interaction of imatinib with human organic ion carriers
- 18483382 1:CAS:528:DC%2BD1cXmtVCmuro%3D 10.1158/1078-0432.CCR-07-4913
- S. Hu R. M. Franke K. K. Filipski C. Hu S. J. Orwick E. A. de Bruijn H. Burger S. D. Baker A. Sparreboom 2008 Interaction of imatinib with human organic ion carriers Clin. Cancer Res. 14 3141 3148 18483382 1:CAS:528: DC%2BD1cXmtVCmuro%3D 10.1158/1078-0432.CCR-07-4913
- (2008) Clin. Cancer Res. , vol.14 , pp. 3141-3148
- Hu, S.¹ Franke, R.M.² Filipski, K.K.³ Hu, C.⁴ Orwick, S.J.⁵ De Bruijn, E.A.⁶ Burger, H.⁷ Baker, S.D.⁸ Sparreboom, A.⁹

36
- 2442700486
- Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: What have we learned?
- DOI 10.1177/0091270004265367
- S. M. Huang L. J. Lesko 2004 Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned? J. Clin. Pharmacol. 44 559 569 15145962 1:CAS:528:DC%2BD2cXltV2ltLw%3D 10.1177/0091270004265367 (Pubitemid 38668017)
- (2004) Journal of Clinical Pharmacology , vol.44 , Issue.6 , pp. 559-569
- Huang, S.-M.¹ Lesko, L.J.²

37
- 44049087422
- Drug interactions/review: New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process
- DOI 10.1177/0091270007312153
- S. M. Huang J. M. Strong L. Zhang K. S. Reynolds S. Nallani R. Temple S. Abraham S. A. Habet R. K. Baweja G. J. Burckart S. Chung P. Colangelo D. Frucht M. D. Green P. Hepp E. Karnaukhova H. S. Ko J. I. Lee P. J. Marroum J. M. Norden W. Qiu A. Rahman S. Sobel T. Stifano K. Thummel X. X. Wei S. Yasuda J. H. Zheng H. Zhao L. J. Lesko 2008 New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process J. Clin. Pharmacol. 48 662 670 18378963 1:CAS:528:DC%2BD1cXns1Kitr4%3D 10.1177/0091270007312153 (Pubitemid 351713150)
- (2008) Journal of Clinical Pharmacology , vol.48 , Issue.6 , pp. 662-670
- Huang, S.-M.¹ Strong, J.M.² Zhang, L.³ Reynolds, K.S.⁴ Nallani, S.⁵ Temple, R.⁶ Abraham, S.⁷ Al Habet, S.⁸ Baweja, R.K.⁹ Burckart, G.J.¹⁰ Chung, S.¹¹ Colangelo, P.¹² Frucht, D.¹³ Green, M.D.¹⁴ Hepp, P.¹⁵ Karnaukhova, E.¹⁶ Ko, H.-S.¹⁷ Lee, J.-I.¹⁸ Marroum, P.J.¹⁹ Norden, J.M.²⁰ more..

38
- 0000006828
- Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)
- DOI 10.1053/cp.1999.v66.a101944
- A. Johne J. Brockmöller S. Bauer A. Maurer M. Langheinrich I. Roots 1999 Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum) Clin. Pharmacol. Ther. 66 338 345 10546917 1:CAS:528:DyaK1MXntlWiu7o%3D 10.1053/cp.1999.v66.a101944 (Pubitemid 29494126)
- (1999) Clinical Pharmacology and Therapeutics , vol.66 , Issue.4 , pp. 338-345
- Johne, A.¹ Brockmoller, J.² Bauer, S.³ Maurer, A.⁴ Langhcinrich, M.⁵ Roots, I.⁶

39
- 25844438751
- Cyclosporine markedly raises the plasma concentrations of repaglinide
- DOI 10.1016/j.clpt.2005.07.005, PII S0009923605003073
- L. I. Kajosaari M. Niemi M. Neuvonen J. Laitila P. J. Neuvonen J. T. Backman 2005 Cyclosporine markedly raises the plasma concentrations of repaglinide Clin. Pharmacol. Ther. 78 388 399 16198658 1:CAS:528: DC%2BD2MXhtVGrsb7J 10.1016/j.clpt.2005.07.005 (Pubitemid 41393674)
- (2005) Clinical Pharmacology and Therapeutics , vol.78 , Issue.4 , pp. 388-399
- Kajosaari, L.I.¹ Niemi, M.² Neuvonen, M.³ Laitila, J.⁴ Neuvonen, P.J.⁵ Backman, J.T.⁶

40
- 70350048926
- Impact of OATP transporters on pharmacokinetics
- 19785645 1:CAS:528:DC%2BD1MXhsVSks7rE 10.1111/j.1476-5381.2009.00430.x
- A. Kalliokoski M. Niemi 2009 Impact of OATP transporters on pharmacokinetics Br. J. Pharmacol. 158 693 705 19785645 1:CAS:528: DC%2BD1MXhsVSks7rE 10.1111/j.1476-5381.2009.00430.x
- (2009) Br. J. Pharmacol. , vol.158 , pp. 693-705
- Kalliokoski, A.¹ Niemi, M.²

41
- 67650106075
- Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol
- 19067419 1:CAS:528:DC%2BD1MXmslCgt7s%3D 10.1002/jps.21618
- Y. Kato T. Miyazaki T. Kano T. Sugiura Y. Kubo A. Tsuji 2009 Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol J. Pharm. Sci. 98 2529 2539 19067419 1:CAS:528:DC%2BD1MXmslCgt7s%3D 10.1002/jps.21618
- (2009) J. Pharm. Sci. , vol.98 , pp. 2529-2539
- Kato, Y.¹ Miyazaki, T.² Kano, T.³ Sugiura, T.⁴ Kubo, Y.⁵ Tsuji, A.⁶

42
- 0037116642
- Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey
- D. W. Kaufman J. P. Kelly L. Rosenberg T. E. Anderson A. A. Mitchell 2002 Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey JAMA 287 337 344 11790213 10.1001/jama.287.3.337 (Pubitemid 34251967)
- (2002) Journal of the American Medical Association , vol.287 , Issue.3 , pp. 337-344
- Kaufman, D.W.¹ Kelly, J.P.² Rosenberg, L.³ Anderson, T.E.⁴ Mitchell, A.A.⁵

43
- 1642422265
- Interactions of Human- and Rat-Organic Anion Transporters with Pravastatin and Cimetidine
- DOI 10.1254/jphs.94.197
- S. Khamdang M. Takeda M. Shimoda R. Noshiro S. Narikawa X. L. Huang A. Enomoto P. Piyachaturawat H. Endou 2004 Interactions of human- and rat-organic anion transporters with pravastatin and cimetidine J. Pharmacol. Sci. 94 197 202 14978359 1:CAS:528:DC%2BD2cXhvVCgt7w%3D 10.1254/jphs.94.197 (Pubitemid 38405135)
- (2004) Journal of Pharmacological Sciences , vol.94 , Issue.2 , pp. 197-202
- Khamdang, S.¹ Takeda, M.² Shimoda, M.³ Noshiro, R.⁴ Narikawa, S.⁵ Huang, X.-L.⁶ Enomoto, A.⁷ Piyachaturawat, P.⁸ Endou, H.⁹

44
- 0032518290
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
- R. B. Kim M. F. Fromm C. Wandel B. Leake A. J. Wood D. M. Roden G. R. Wilkinson 1998 The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors J. Clin. Invest. 101 289 294 9435299 1:CAS:528:DyaK1cXmtF2jtw%3D%3D 10.1172/JCI1269 (Pubitemid 28067324)
- (1998) Journal of Clinical Investigation , vol.101 , Issue.2 , pp. 289-294
- Kim, R.B.¹ Fromm, M.F.² Wandel, C.³ Leake, B.⁴ Wood, A.J.J.⁵ Roden, D.M.⁶ Wilkinson, G.R.⁷

45
- 0022634295
- Dose-dependence of the nifedipine-digoxin interaction?
- W. Kirch H. J. Hutt P. Dylewicz K. J. Gräf E. E. Ohnhaus 1986 Dose-dependence of the nifedipine-digoxin interaction? Clin. Pharmacol. Ther. 39 35 39 3943268 1:CAS:528:DyaL28XotFGntA%3D%3D 10.1038/clpt.1986.6 (Pubitemid 16166963)
- (1986) Clinical Pharmacology and Therapeutics , vol.39 , Issue.1 , pp. 35-39
- Kirch, W.¹ Hutt, H.J.² Dylewicz, P.³

46
- 72749106653
- The complexities of antiretroviral drug-drug interactions: Role of ABC and SLC transporters
- 20004485 1:CAS:528:DC%2BC3cXpt1Gj 10.1016/j.tips.2009.10.001
- O. Kis K. Robillard G. N. Chan R. Bendayan 2010 The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters Trends Pharmacol. Sci. 31 22 35 20004485 1:CAS:528:DC%2BC3cXpt1Gj 10.1016/j.tips.2009. 10.001
- (2010) Trends Pharmacol. Sci. , vol.31 , pp. 22-35
- Kis, O.¹ Robillard, K.² Chan, G.N.³ Bendayan, R.⁴

47
- 78649656801
- Uptake transporters of the human OATP family: Molecular characteristics, substrates, their role in drugdrug interactions, and functional consequences of polymorphisms
- 21103967 10.1007/978-3-642-14541-4-1 1:CAS:528:DC%2BC3MXmsFWrsrs%3D
- J. König 2011 Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drugdrug interactions, and functional consequences of polymorphisms Handb. Exp. Pharmacol. 201 1 28 21103967 10.1007/978-3-642-14541-4-1 1:CAS:528:DC%2BC3MXmsFWrsrs%3D
- (2011) Handb. Exp. Pharmacol. , vol.201 , pp. 1-28
- König, J.¹

48
- 0032698091
- Longitudinal assessment of a P-glycoprotein-mediated drug interaction of valspodar on digoxin
- DOI 10.1053/cp.1999.v66.a101462
- J. M. Kovarik L. Rigaudy M. Guerret C. Gerbeau K. L. Rost 1999 Longitudinal assessment of a P-glycoproteinmediated drug interaction of valspodar on digoxin Clin. Pharmacol. Ther. 66 391 400 10546923 1:CAS:528:DyaK1MXntlWhsr4%3D 10.1053/cp.1999.v66.a101462 (Pubitemid 29494132)
- (1999) Clinical Pharmacology and Therapeutics , vol.66 , Issue.4 , pp. 391-400
- Kovarik, J.M.¹ Rigaudy, L.² Guerret, M.³ Gerbeau, C.⁴ Rost, K.-L.⁵

49
- 79951497709
- P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions
- 21417789 10.1515/DMDI.2010.006
- Y. S. Kumar D. Adukondalu D. Sathish Y. V. Vishnu G. Ramesh A. B. Latha P. C. Reddy M. Sarangapani Y. M. Rao 2010 P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions Drug Metabol. Drug Interact. 25 3 16 21417789 10.1515/DMDI.2010.006
- (2010) Drug Metabol. Drug Interact. , vol.25 , pp. 3-16
- Kumar, Y.S.¹ Adukondalu, D.² Sathish, D.³ Vishnu, Y.V.⁴ Ramesh, G.⁵ Latha, A.B.⁶ Reddy, P.C.⁷ Sarangapani, M.⁸ Rao, Y.M.⁹

50
- 0031716603
- Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys
- DOI 10.1006/toxs.1998.2481
- S. A. Lacy M. J. Hitchcock W. A. Lee P. Tellier K. C. Cundy 1998 Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys Toxicol. Sci. 44 97 106 9742650 1:CAS:528:DyaK1cXmtVWksb0%3D 10.1093/toxsci/44.2.97 (Pubitemid 28415221)
- (1998) Toxicological Sciences , vol.44 , Issue.2 , pp. 97-106
- Lacy, S.A.¹ Hitchcock, M.J.M.² Lee, W.A.³ Tellier, P.⁴ Cundy, K.C.⁵

51
- 0030941451
- Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis
- 9058615 1:CAS:528:DyaK2sXitlOltLk%3D 10.1097/00042560-199700001-00006
- J. P. Lalezari B. D. Kuppermann 1997 Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14 Suppl1 S27 S31 9058615 1:CAS:528:DyaK2sXitlOltLk%3D 10.1097/00042560-199700001-00006
- (1997) J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. , vol.14 , Issue.SUPPL.1
- Lalezari, J.P.¹ Kuppermann, B.D.²

52
- 0032540001
- HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
- DOI 10.1021/bi972709x
- C. G. Lee M. M. Gottesman C. O. Cardarelli M. Ramachandra K. T. Jeang S. V. Ambudkar I. Pastan S. Dey 1998 HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter Biochemistry 37 3594 3601 9530286 1:CAS:528:DyaK1cXht12ltL4%3D 10.1021/bi972709x (Pubitemid 28162914)
- (1998) Biochemistry , vol.37 , Issue.11 , pp. 3594-3601
- Lee, C.G.L.¹ Gottesman, M.M.² Cardarelli, C.O.³ Ramachandra, M.⁴ Jeang, K.-T.⁵ Ambudkar, S.V.⁶ Pastan, I.⁷ Dey, S.⁸

53
- 0037373594
- Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol
- DOI 10.1067/mcp.2003.26
- J. J. Lilja J. T. Backman J. Laitila H. Luurila P. J. Neuvonen 2003 Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol Clin. Pharmacol. Ther. 73 192 198 12621384 1:CAS:528:DC%2BD3sXitFagt74%3D 10.1067/mcp.2003.26 (Pubitemid 36269670)
- (2003) Clinical Pharmacology and Therapeutics , vol.73 , Issue.3 , pp. 192-198
- Lilja, J.J.¹ Backman, J.T.² Laitila, J.³ Luurila, H.⁴ Neuvonen, P.J.⁵

54
- 27644463532
- Effects of orange juice on the pharmacokinetics of atenolol
- DOI 10.1007/s00228-005-0930-9
- J. J. Lilja K. Raaska P. J. Neuvonen 2005 Effects of orange juice on the pharmacokinetics of atenolol Eur. J. Clin. Pharmacol. 61 337 340 15983823 1:CAS:528:DC%2BD2MXmsFWlsLs%3D 10.1007/s00228-005-0930-9 (Pubitemid 41569306)
- (2005) European Journal of Clinical Pharmacology , vol.61 , Issue.5-6 , pp. 337-340
- Lilja, J.J.¹ Raaska, K.² Neuvonen, P.J.³

55
- 0030055770
- St John's wort for depression - An overview and meta-analysis of randomised clinical trials
- K. Linde G. Ramirez C. D. Mulrow A. Pauls W. Weidenhammer D. Melchart 1996 St John's wort for depression-an overview and meta-analysis of randomised clinical trials BMJ 313 253 258 8704532 1:STN:280:DyaK28zit1Klug%3D%3D 10.1136/bmj.313.7052.253 (Pubitemid 26254730)
- (1996) British Medical Journal , vol.313 , Issue.7052 , pp. 253-258
- Linde, K.¹ Ramirez, G.² Mulrow, C.D.³ Pauls, A.⁴ Weidenhammer, W.⁵ Melchart, D.⁶

56
- 77951091171
- Therapeutic implications of renal anionic drug transporters
- 20227439 1:CAS:528:DC%2BC3cXksF2qur0%3D 10.1016/j.pharmthera.2010.02.007
- R. Masereeuw F. G. Russel 2010 Therapeutic implications of renal anionic drug transporters Pharmacol. Ther. 126 200 216 20227439 1:CAS:528: DC%2BC3cXksF2qur0%3D 10.1016/j.pharmthera.2010.02.007
- (2010) Pharmacol. Ther. , vol.126 , pp. 200-216
- Masereeuw, R.¹ Russel, F.G.²

57
- 33644914487
- Flavonoid-drug interactions: Effects of flavonoids on ABC transporters
- 16455109 1:CAS:528:DC%2BD28XisF2qsb0%3D 10.1016/j.lfs.2005.12.003
- M. E. Morris S. Zhang 2006 Flavonoid-drug interactions: effects of flavonoids on ABC transporters Life Sci. 78 2116 2130 16455109 1:CAS:528:DC%2BD28XisF2qsb0%3D 10.1016/j.lfs.2005.12.003
- (2006) Life Sci. , vol.78 , pp. 2116-2130
- Morris, M.E.¹ Zhang, S.²

58
- 0033815816
- Nonsteroidal antiinflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1
- 10991954 1:CAS:528:DC%2BD3cXnt1ygtL0%3D
- A. S. Mulato E. S. Ho T. Cihlar 2000 Nonsteroidal antiinflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1 J. Pharmacol. Exp. Ther. 295 10 15 10991954 1:CAS:528:DC%2BD3cXnt1ygtL0%3D
- (2000) J. Pharmacol. Exp. Ther. , vol.295 , pp. 10-15
- Mulato, A.S.¹ Ho, E.S.² Cihlar, T.³

59
- 0036202184
- Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: A new twist on an old interaction
- DOI 10.1177/0091270002424013
- A. L. Neuhofel J. H. Wilton J. M. Victory L. G. Hejmanowsk G. W. Amsden 2002 Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction J. Clin. Pharmacol. 42 461 466 11936572 1:CAS:528:DC%2BD38Xjt1ynsrY%3D 10.1177/0091270002424013 (Pubitemid 34259781)
- (2002) Journal of Clinical Pharmacology , vol.42 , Issue.4 , pp. 461-466
- Neuhofel, A.L.¹ Wilton, J.H.² Victory, J.M.³ Hejmanowski, L.G.⁴ Amsden, G.W.⁵

60
- 33845420011
- Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
- DOI 10.1016/j.clpt.2006.09.003, PII S0009923606003602
- P. J. Neuvonen M. Niemi J. T. Backman 2006 Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance Clin. Pharmacol. Ther. 80 565 581 17178259 1:CAS:528:DC%2BD28XhtleisLfE 10.1016/j.clpt.2006.09.003 (Pubitemid 44908269)
- (2006) Clinical Pharmacology and Therapeutics , vol.80 , Issue.6 , pp. 565-581
- Neuvonen, P.J.¹ Niemi, M.² Backman, J.T.³

61
- 0142093523
- Gemfibrozil considerably increases the plasma concentrations of rosiglitazone
- DOI 10.1007/s00125-003-1181-x
- M. Niemi J. T. Backman M. Neuvonen P. J. Neuvonen 2003 Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics and pharmacodynamics of repaglinide: potentially hazardous interaction between gemfibrozil and repaglinide Diabetologia 46 347 351 12687332 1:CAS:528:DC%2BD3sXnvVCgtbg%3D 10.1007/s00125-003-1181-x (Pubitemid 37297200)
- (2003) Diabetologia , vol.46 , Issue.10 , pp. 1319-1323
- Niemi, M.¹ Backman, J.T.² Granfors, M.³ Laitila, J.⁴ Neuvonen, M.⁵ Neuvonen, P.J.⁶

62
- 20444466590
- Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
- DOI 10.1016/j.clpt.2005.01.018, PII S0009923605000469
- M. Niemi J. T. Backman L. I. Kajosaari J. B. Leathart M. Neuvonen A. K. Daly M. Eichelbaum K. T. Kivistö P. J. Neuvonen 2005 Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics Clin. Pharmacol. Ther. 77 468 478 15961978 1:CAS:528: DC%2BD2MXlt1Gqtrc%3D 10.1016/j.clpt.2005.01.018 (Pubitemid 40824960)
- (2005) Clinical Pharmacology and Therapeutics , vol.77 , Issue.6 , pp. 468-478
- Niemi, M.¹ Backman, J.T.² Kajosaari, L.I.³ Leathart, J.B.⁴ Neuvonen, M.⁵ Daly, A.K.⁶ Eichelbaum, M.⁷ Kivisto, K.T.⁸ Neuvonen, P.J.⁹

63
- 34548103493
- Role of OATP transporters in the disposition of drugs
- DOI 10.2217/14622416.8.7.787
- M. Niemi 2007 Role of OATP transporters in the disposition of drugs Pharmacogenomics 8 787 802 18240907 1:CAS:528:DC%2BD2sXnvVers7k%3D 10.2217/14622416.8.7.787 (Pubitemid 47288978)
- (2007) Pharmacogenomics , vol.8 , Issue.7 , pp. 787-802
- Niemi, M.¹

64
- 33644891064
- MDR- and CYP3A4-mediated drugherbal interactions
- 16442130 1:CAS:528:DC%2BD28XisF2qsbs%3D 10.1016/j.lfs.2005.12.010
- D. Pal A. K. Mitra 2006 MDR- and CYP3A4-mediated drugherbal interactions Life Sci. 78 2131 2145 16442130 1:CAS:528:DC%2BD28XisF2qsbs%3D 10.1016/j.lfs.2005.12.010
- (2006) Life Sci. , vol.78 , pp. 2131-2145
- Pal, D.¹ Mitra, A.K.²

65
- 0035710125
- Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A
- J. W. Park R. Siekmeier P. Lattke M. Merz C. Mix S. Schüler W. Jaross 2001 Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A J. Cardiovasc. Pharmacol. Ther. 6 351 361 11907637 1:CAS:528:DC%2BD38XitVCrsb0%3D 10.1177/107424840100600404 (Pubitemid 34141820)
- (2001) Journal of Cardiovascular Pharmacology and Therapeutics , vol.6 , Issue.4 , pp. 351-361
- Park, J.-W.¹ Siekmeier, R.² Lattke, P.³ Merz, M.⁴ Mix, C.⁵ Schuiler, S.⁶ Jaross, W.⁷

66
- 0029944941
- Itraconazole increases serum digoxin concentration
- J. Partanen K. M. Jalava P. J. Neuvonen 1996 Itraconazole increases serum digoxin concentration Pharmacol. Toxicol. 79 274 276 8936563 1:CAS:528:DyaK28XmslGitbo%3D 10.1111/j.1600-0773.1996.tb00273.x (Pubitemid 26374172)
- (1996) Pharmacology and Toxicology , vol.79 , Issue.5 , pp. 274-276
- Partanen, J.¹ Jalava, K.-M.² Neuvonen, P.J.³

67
- 0020614078
- Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration
- K. E. Pedersen B. D. Christiansen K. Kjaer N. A. Klitgaard F. Nielsen-Kudsk 1983 Verapamil-induced changes in digoxin kinetics and intraerythrocytic sodium concentration Clin. Pharmacol. Ther. 34 8 13 6861442 1:CAS:528:DyaL3sXltVSnsLk%3D 10.1038/clpt.1983.121 (Pubitemid 13073295)
- (1983) Clinical Pharmacology and Therapeutics , vol.34 , Issue.1 , pp. 8-13
- Pedersen, K.E.¹ Christiansen, B.D.² Kjaer, K.³

68
- 0035671937
- Saint John's wort: An in vitro analysis of P-glycoprotein induction due to extended exposure
- M. D. Perloff L. L. von Moltke E. Störmer R. I. Shader D. J. Greenblatt 2001 Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure Br. J. Pharmacol. 134 1601 1608 11739235 1:CAS:528:DC%2BD38XkvVei 10.1038/sj.bjp.0704399 (Pubitemid 34038092)
- (2001) British Journal of Pharmacology , vol.134 , Issue.8 , pp. 1601-1608
- Perloff, M.D.¹ Von Moltke, L.L.² Stormer, E.³ Shader, R.I.⁴ Greenblatt, D.J.⁵

69
- 3042723720
- Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients
- M. Pirmohamed S. James S. Meakin C. Green A. K. Scott T. J. Walley K. Farrar B. K. Park A. M. Breckenridge 2004 Adverse drug reactions as cause of admission to hospital: prospective analysis of 18820 patients BMJ 329 15 19 15231615 10.1136/bmj.329.7456.15 (Pubitemid 38869995)
- (2004) British Medical Journal , vol.329 , Issue.7456 , pp. 15-19
- Pirmohamed, M.¹ James, S.² Meakin, S.³ Green, C.⁴ Scott, A.K.⁵ Walley, T.J.⁶ Farrar, K.⁷ Park, B.K.⁸ Breckenridge, A.M.⁹

70
- 0036787498
- Prevalence of complementary and alternative medicine use: State-specific estimates from the 2001 Behavioral Risk Factor Surveillance System
- 12356602 10.2105/AJPH.92.10.1598
- A. P. Rafferty H. B. McGee C. E. Miller M. Reyes 2002 Prevalence of complementary and alternative medicine use: state-specific estimates from the 2001 Behavioral Risk Factor Surveillance System Am. J. Public Health 92 1598 1600 12356602 10.2105/AJPH.92.10.1598
- (2002) Am. J. Public Health , vol.92 , pp. 1598-1600
- Rafferty, A.P.¹ McGee, H.B.² Miller, C.E.³ Reyes, M.⁴

71
- 0021992746
- Quinidine-digoxin interaction: Are the pharmacokinetics of both drugs altered?
- H. Rameis 1985 Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered? Int. J. Clin. Pharmacol. Ther. Toxicol. 23 145 153 3997300 1:CAS:528:DyaL2MXkvFygsbk%3D (Pubitemid 15100828)
- (1985) International Journal of Clinical Pharmacology Therapy and Toxicology , vol.23 , Issue.3 , pp. 145-153
- Rameis, H.¹

72
- 33644692007
- P-glycoprotein recognition of substrates and circumvention through rational drug design
- DOI 10.1021/mp0500871
- T. J. Raub 2006 P-glycoprotein recognition of substrates and circumvention through rational drug design Mol. Pharm. 3 3 25 16686365 1:CAS:528:DC%2BD2MXhtlagu7%2FP 10.1021/mp0500871 (Pubitemid 43331747)
- (2006) Molecular Pharmaceutics , vol.3 , Issue.1 , pp. 3-25
- Raub, T.J.¹

73
- 0027327029
- Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients
- M. B. Regazzi I. Iacona C. Campana V. Raddato C. Lesi G. Perani A. Gavazzi M. Viganò 1993 Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients Transplant. Proc. 25 2732 2734 8356729 1:STN:280:DyaK3szmt1egsw%3D%3D (Pubitemid 23239614)
- (1993) Transplantation Proceedings , vol.25 , Issue.4 , pp. 2732-2734
- Regazzi, M.B.¹ Iacona, I.² Campana, C.³ Raddato, V.⁴ Lesi, C.⁵ Perani, G.⁶ Gavazzi, A.⁷ Vigano, M.⁸

74
- 0033918159
- Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology
- M. A. Richardson T. Sanders J. L. Palmer A. Greisinger S. E. Singletary 2000 Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology J. Clin. Oncol. 18 2505 2514 10893280 1:STN:280:DC%2BD3czlt1SnsA%3D%3D (Pubitemid 30432515)
- (2000) Journal of Clinical Oncology , vol.18 , Issue.13 , pp. 2505-2514
- Richardson, M.A.¹ Sanders, T.² Palmer, J.L.³ Greisinger, A.⁴ Singletary, S.E.⁵

75
- 33847139479
- Organic anion transporters of the SLC22 family: Biopharmaceutical, physiological, and pathological roles
- DOI 10.1007/s11095-006-9181-4
- A. N. Rizwan G. Burckhardt 2007 Organic anion transporters of the SLC22 family: biopharmaceutical, physiological, and pathological roles Pharm. Res. 24 450 470 17245646 1:CAS:528:DC%2BD2sXhslWisr4%3D 10.1007/s11095-006-9181-4 (Pubitemid 46295167)
- (2007) Pharmaceutical Research , vol.24 , Issue.3 , pp. 450-470
- Rizwan, A.N.¹ Burckhardt, G.²

76
- 0019497381
- Pharmacokinetics of cephradine given intravenously with and without probenecid
- D. H. Roberts M. J. Kendall D. B. Jack P. G. Welling 1981 Pharmacokinetics of cephradine given intravenously with and without probenecid Br. J. Clin. Pharmacol. 11 561 564 7272172 1:CAS:528:DyaL3MXksFCmu7s%3D (Pubitemid 11112436)
- (1981) British Journal of Clinical Pharmacology , vol.11 , Issue.6 , pp. 561-564
- Roberts, D.H.¹ Kendall, M.J.² Jack, D.B.³ Welling, P.G.⁴

77
- 0037457802
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: An overview
- DOI 10.1016/S0169-409X(02)00169-2, PII S0169409X02001692
- A. H. Schinkel J. W. Jonker 2003 Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview Adv. Drug Deliv. Rev. 55 3 29 12535572 1:CAS:528:DC%2BD3sXivVWnsQ%3D%3D 10.1016/S0169-409X(02)00169-2 (Pubitemid 36078452)
- (2003) Advanced Drug Delivery Reviews , vol.55 , Issue.1 , pp. 3-29
- Schinkel, A.H.¹ Jonker, J.W.²

78
- 16344378672
- Grapefruit juice ingestion significantly reduces talinolol bioavailability
- DOI 10.1016/j.clpt.2004.11.111
- U. I. Schwarz D. Seemann R. Oertel S. Miehlke E. Kuhlisch M. F. Fromm R. B. Kim D. G. Bailey W. Kirch 2005 Grapefruit juice ingestion significantly reduces talinolol bioavailability Clin. Pharmacol. Ther. 77 291 301 15903127 1:CAS:528:DC%2BD2MXjtVyksbs%3D 10.1016/j.clpt.2004.11.111 (Pubitemid 40470385)
- (2005) Clinical Pharmacology and Therapeutics , vol.77 , Issue.4 , pp. 291-301
- Schwarz, U.I.¹ Seemann, D.² Oertel, R.³ Miehlke, S.⁴ Kuhlisch, E.⁵ Fromm, M.F.⁶ Kim, R.B.⁷ Bailey, D.G.⁸ Kirch, W.⁹

79
- 33748754525
- Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition
- DOI 10.1111/j.1365-2125.2005.02519.x
- U. I. Schwarz P. E. Johnston D. G. Bailey R. B. Kim G. Mayo A. Milstone 2006 Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition Br. J. Clin. Pharmacol. 62 485 491 16995870 1:CAS:528: DC%2BD28Xht1ehtbjJ 10.1111/j.1365-2125.2005.02519.x (Pubitemid 44401532)
- (2006) British Journal of Clinical Pharmacology , vol.62 , Issue.4 , pp. 485-491
- Schwarz, U.I.¹ Johnston, P.E.² Bailey, D.G.³ Kim, R.B.⁴ Mayo, G.⁵ Milstone, A.⁶

80
- 34247244726
- Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol
- DOI 10.1038/sj.clpt.6100191, PII 6100191
- U. I. Schwarz H. Hanso R. Oertel S. Miehlke E. Kuhlisch H. Glaeser M. Hitzl G. K. Dresser R. B. Kim W. Kirch 2007 Induction of intestinal P-glycoprotein by St John's wort reduces the oral bioavailability of talinolol Clin. Pharmacol. Ther. 81 669 678 17392718 1:CAS:528:DC%2BD2sXlsFCqsL0%3D 10.1038/sj.clpt.6100191 (Pubitemid 46625125)
- (2007) Clinical Pharmacology and Therapeutics , vol.81 , Issue.5 , pp. 669-678
- Schwarz, U.I.¹ Hanso, H.² Oertel, R.³ Miehlke, S.⁴ Kuhlisch, E.⁵ Glaeser, H.⁶ Hitzl, M.⁷ Dresser, G.K.⁸ Kim, R.B.⁹ Kirch, W.¹⁰

81
- 78649925436
- Grapefruitdrug interactions
- 21142260 1:CAS:528:DC%2BC3MXhvVGhsLY%3D 10.2165/11585250-000000000-00000
- K. Seden L. Dickinson S. Khoo D. Back 2010 Grapefruitdrug interactions Drugs 70 2373 2407 21142260 1:CAS:528:DC%2BC3MXhvVGhsLY%3D 10.2165/11585250- 000000000-00000
- (2010) Drugs , vol.70 , pp. 2373-2407
- Seden, K.¹ Dickinson, L.² Khoo, S.³ Back, D.⁴

82
- 0030855487
- Expression cloning and characterization of a novel multispecific organic anion transporter
- DOI 10.1074/jbc.272.30.18526
- T. Sekine N. Watanabe M. Hosoyamada Y. Kanai H. Endou 1997 Expression cloning and characterization of a novel multispecific organic anion transporter J. Biol. Chem. 272 18526 18529 9228014 1:CAS:528:DyaK2sXltVSgsrg%3D 10.1074/jbc.272.30.18526 (Pubitemid 27318187)
- (1997) Journal of Biological Chemistry , vol.272 , Issue.30 , pp. 18526-18529
- Sekine, T.¹ Watanabe, N.² Hosoyamada, M.³ Kanai, Y.⁴ Endou, H.⁵

83
- 35548933763
- P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution
- DOI 10.1124/dmd.107.017723
- N. Shaik N. Giri G. Pan W. F. Elmquist 2007 P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution Drug Metab. Dispos. 35 2076 2085 17709369 1:CAS:528:DC%2BD2sXht1Cnu7jI 10.1124/dmd.107.017723 (Pubitemid 350005198)
- (2007) Drug Metabolism and Disposition , vol.35 , Issue.11 , pp. 2076-2085
- Shaik, N.¹ Giri, N.² Pan, G.³ Elmquist, W.F.⁴

84
- 4644301418
- Gemfibrozil and its glucoronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: Analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil
- DOI 10.1124/jpet.104.068536
- Y. Shitara M. Hirano H. Sato Y. Sugiyama 2004 Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug interaction between cerivastatin and gemfibrozil J. Pharmacol. Exp. Ther. 311 228 236 15194707 1:CAS:528:DC%2BD2cXosVKrt7g%3D 10.1124/jpet.104.068536 (Pubitemid 39287802)
- (2004) Journal of Pharmacology and Experimental Therapeutics , vol.311 , Issue.1 , pp. 228-236
- Shitara, Y.¹ Hirano, M.² Sato, H.³ Sugiyama, Y.⁴

85
- 3542992126
- Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine
- DOI 10.1016/j.clpt.2004.03.010, PII S0009923604001389
- S. G. Simonson A. Raza P. D. Martin P. D. Mitchell J. A. Jarcho C. D. Brown A. S. Windass D. W. Schneck 2004 Rosuvastatin pharmacokinetics in heart transplant recipients administered an antirejection regimen including cyclosporine Clin. Pharmacol. Ther. 76 167 177 15289793 1:CAS:528: DC%2BD2cXmt1Ogu78%3D 10.1016/j.clpt.2004.03.010 (Pubitemid 39013406)
- (2004) Clinical Pharmacology and Therapeutics , vol.76 , Issue.2 , pp. 167-177
- Simonson, S.G.¹ Raza, A.² Martin, P.D.³ Mitchell, P.D.⁴ Jarcho, J.A.⁵ Brown, C.D.A.⁶ Windass, A.S.⁷ Schneck, D.W.⁸

86
- 33747866680
- Role of the liverspecific transporters OATP1B1 and OATP1B3 in governing drug elimination
- 16863454 1:CAS:528:DC%2BD2MXhtVGjsLvJ 10.1517/17425255.1.3.429
- N. F. Smith W. D. Figg A. Sparreboom 2005 Role of the liverspecific transporters OATP1B1 and OATP1B3 in governing drug elimination Expert Opin. Drug Metab. Toxicol. 1 429 445 16863454 1:CAS:528:DC%2BD2MXhtVGjsLvJ 10.1517/17425255.1.3.429
- (2005) Expert Opin. Drug Metab. Toxicol. , vol.1 , pp. 429-445
- Smith, N.F.¹ Figg, W.D.² Sparreboom, A.³

87
- 0033761671
- Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials
- 11059503 1:STN:280:DC%2BD3crgslKksw%3D%3D 10.1089/acm.2000.6.415
- A. Sparber J. C. Wootton L. Bauer G. Curt D. Eisenberg T. Levin S. M. Steinberg 2000 Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials J. Altern. Complement. Med. 6 415 422 11059503 1:STN:280:DC%2BD3crgslKksw%3D%3D 10.1089/acm.2000.6.415
- (2000) J. Altern. Complement. Med. , vol.6 , pp. 415-422
- Sparber, A.¹ Wootton, J.C.² Bauer, L.³ Curt, G.⁴ Eisenberg, D.⁵ Levin, T.⁶ Steinberg, S.M.⁷

88
- 48749084010
- Physiology, structure, and regulation of the cloned organic anion transporters
- 18668434 1:CAS:528:DC%2BD1cXpt1Snurw%3D 10.1080/00498250801927435
- C. Srimaroeng J. L. Perry J. B. Pritchard 2008 Physiology, structure, and regulation of the cloned organic anion transporters Xenobiotica 38 889 935 18668434 1:CAS:528:DC%2BD1cXpt1Snurw%3D 10.1080/00498250801927435
- (2008) Xenobiotica , vol.38 , pp. 889-935
- Srimaroeng, C.¹ Perry, J.L.² Pritchard, J.B.³

89
- 79952809873
- Organic anion transporting polypeptides (OATPs): Regulation of expression and function
- 21395542 1:CAS:528:DC%2BC3MXltlGjsbw%3D 10.2174/138920011795016863
- M. Svoboda J. Riha K. Wlcek W. Jaeger T. Thalhammer 2011 Organic anion transporting polypeptides (OATPs): regulation of expression and function Curr. Drug Metab. 12 139 153 21395542 1:CAS:528:DC%2BC3MXltlGjsbw%3D 10.2174/138920011795016863
- (2011) Curr. Drug Metab. , vol.12 , pp. 139-153
- Svoboda, M.¹ Riha, J.² Wlcek, K.³ Jaeger, W.⁴ Thalhammer, T.⁵

90
- 0037376163
- Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient
- 12488248 1:CAS:528:DC%2BD3sXjsVajsr0%3D
- D. H. Sweet L. M. Chan R. Walden X. P. Yang D. S. Miller J. B. Pritchard 2003 Organic anion transporter 3 (Slc22a8) is a dicarboxylate exchanger indirectly coupled to the Na+ gradient Am. J. Physiol. Renal. Physiol. 284 F763 769 12488248 1:CAS:528:DC%2BD3sXjsVajsr0%3D
- (2003) Am. J. Physiol. Renal. Physiol. , vol.284 , pp. 763-769
- Sweet, D.H.¹ Chan, L.M.² Walden, R.³ Yang, X.P.⁴ Miller, D.S.⁵ Pritchard, J.B.⁶

91
- 43149118341
- The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox)
- 18468555 10.1016/j.drudis.2007.12.010 1:CAS:528:DC%2BD1cXlvVWntL8%3D
- G. Szakács A. Váradi C. Ozvegy-Laczka B. Sarkadi 2008 The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox) Drug Discov. Today 13 379 393 18468555 10.1016/j.drudis.2007.12.010 1:CAS:528:DC%2BD1cXlvVWntL8%3D
- (2008) Drug Discov. Today , vol.13 , pp. 379-393
- Szakács, G.¹ Váradi, A.² Ozvegy-Laczka, C.³ Sarkadi, B.⁴

92
- 25644452793
- 2 receptor antagonists by rat and human renal organic anion and cation transporters
- DOI 10.1124/jpet.105.088104
- H. Tahara H. Kusuhara H. Endou H. Koepsell T. Imaoka E. Fuse Y. Sugiyama 2005 A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters J. Pharmacol. Exp. Ther. 315 337 345 16006492 1:CAS:528:DC%2BD2MXhtVOks7vF 10.1124/jpet.105.088104 (Pubitemid 41380529)
- (2005) Journal of Pharmacology and Experimental Therapeutics , vol.315 , Issue.1 , pp. 337-345
- Tahara, H.¹ Kusuhara, H.² Endou, H.³ Koepsell, H.⁴ Imaoka, T.⁵ Fuse, E.⁶ Sugiyama, Y.⁷

93
- 0035843770
- Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters
- DOI 10.1016/S0014-2999(01)00962-1, PII S0014299901009621
- M. Takeda S. Narikawa M. Hosoyamada S. H. Cha T. Sekine H. Endou 2001 Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters Eur. J. Pharmacol. 419 113 120 11426832 1:CAS:528:DC%2BD3MXksFCktrw%3D 10.1016/S0014-2999(01)00962-1 (Pubitemid 32568209)
- (2001) European Journal of Pharmacology , vol.419 , Issue.2-3 , pp. 113-120
- Takeda, M.¹ Narikawa, S.² Hosoyamada, M.³ Ho Cha, S.⁴ Sekine, T.⁵ Endou, H.⁶

94
- 0347318099
- Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors
- DOI 10.1016/j.ejphar.2003.10.017
- M. Takeda R. Noshiro M. L. Onozato A. Tojo H. Hasannejad X. L. Huang S. Narikawa H. Endou 2004 Evidence for a role of human organic anion transporters in the muscular side effects of HMG-CoA reductase inhibitors Eur. J. Pharmacol. 483 133 138 14729100 1:CAS:528:DC%2BD2cXjsFajsg%3D%3D 10.1016/j.ejphar.2003.10. 017 (Pubitemid 38068393)
- (2004) European Journal of Pharmacology , vol.483 , Issue.2-3 , pp. 133-138
- Takeda, M.¹ Noshiro, R.² Onozato, M.L.³ Tojo, A.⁴ Hasannejad, H.⁵ Huang, X.-L.⁶ Narikawa, S.⁷ Endou, H.⁸

95
- 77955925948
- Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren
- 20664534 1:CAS:528:DC%2BC3cXhtVCntbfK 10.1038/clpt.2010.101
- T. Tapaninen P. J. Neuvonen M. Niemi 2010 Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren Clin. Pharmacol. Ther. 88 339 342 20664534 1:CAS:528:DC%2BC3cXhtVCntbfK 10.1038/clpt.2010.101
- (2010) Clin. Pharmacol. Ther. , vol.88 , pp. 339-342
- Tapaninen, T.¹ Neuvonen, P.J.² Niemi, M.³

96
- 78649244514
- Herb-drug pharmacokinetic interactions reviewed
- 21067427 1:CAS:528:DC%2BC3cXhsVeksbnM 10.1517/17425255.2010.529129
- C. Tarirai A. M. Viljoen J. H. Hamman 2010 Herb-drug pharmacokinetic interactions reviewed Expert Opin. Drug Metab. Toxicol. 6 1515 1538 21067427 1:CAS:528:DC%2BC3cXhsVeksbnM 10.1517/17425255.2010.529129
- (2010) Expert Opin. Drug Metab. Toxicol. , vol.6 , pp. 1515-1538
- Tarirai, C.¹ Viljoen, A.M.² Hamman, J.H.³

97
- 0030726054
- Nephrotoxicity of beta-lactam antibiotics: Mechanisms and strategies for prevention
- DOI 10.1007/s004670050386
- B. M. Tune 1997 Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention Pediatr. Nephrol. 11 768 772 9438663 1:STN:280:DyaK1c%2FpvFGjsw%3D%3D 10.1007/s004670050386 (Pubitemid 27520549)
- (1997) Pediatric Nephrology , vol.11 , Issue.6 , pp. 768-772
- Tune, B.M.¹

98
- 84855459072
- 2011 U.S. Department of Health and Human Services
- U.S. Department of Health and Human Services. http://AIDSinfo.nih.gov (2011).

99
- 33846448814
- US FDA
- US FDA, Guidance for Industry: Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling. http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm 072101.pdf (2010).
- (2010) Guidance for Industry: Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling

100
- 84855461716
- US FDA, Drug Development and Drug Interactions 2011
- US FDA, Drug Development and Drug Interactions. http://www.fda.gov/Drugs/ DevelopmentApprovalProcess/DevelopmentResources/DrugInteractionsLabeling/ ucm080499.htm (2011).

101
- 0036326062
- Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures
- DOI 10.1124/dmd.30.8.924
- J. van Gelder S. Deferme L. Naesens E. De Clercq G. van den Mooter R. Kinget P. Augustijns 2002 Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures Drug Metab. Dispos. 30 924 930 12124311 10.1124/dmd.30.8.924 (Pubitemid 34815423)
- (2002) Drug Metabolism and Disposition , vol.30 , Issue.8 , pp. 924-930
- Van Gelder, J.¹ Deferme, S.² Naesens, L.³ De Clercq, E.⁴ Van Den Mooter, G.⁵ Kinget, R.⁶ Augustijns, P.⁷

102
- 0036286921
- Effect of St John's wort on the pharmacokenetics of fexofenadine
- DOI 10.1067/mcp.2002.124080
- Z. Wang M. A. Hamman S. M. Huang L. J. Lesko S. D. Hall 2002 Effect of St John's wort on the pharmacokinetics of fexofenadine Clin. Pharmacol. Ther. 71 414 420 12087344 1:CAS:528:DC%2BD38XlslCktrk%3D 10.1067/mcp.2002.124080 (Pubitemid 34701348)
- (2002) Clinical Pharmacology and Therapeutics , vol.71 , Issue.6 , pp. 414-420
- Wang, Z.¹ Hamman, M.A.² Huang, S.-M.³ Lesko, L.J.⁴ Hall, S.D.⁵

103
- 0033865280
- Oral bioavailability of digoxin is enhanced by talinolol: Evidence for involvement of intestinal P-glycoprotein
- DOI 10.1067/mcp.2000.107579
- K. Westphal A. Weinbrenner T. Giessmann M. Stuhr G. Franke M. Zschiesche R. Oertel B. Terhaag H. K. Kroemer W. Siegmund 2000 Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein Clin. Pharmacol. Ther. 68 6 12 10945310 1:CAS:528: DC%2BD3cXlvVOrs7o%3D 10.1067/mcp.2000.107579 (Pubitemid 30609821)
- (2000) Clinical Pharmacology and Therapeutics , vol.68 , Issue.1 , pp. 6-12
- Westphal, K.¹ Weinbrenner, A.² Giessmann, T.³ Stuhr, M.⁴ Franke, G.⁵ Zschiesche, M.⁶ Oertel, R.⁷ Terhaag, B.⁸ Kroemer, H.K.⁹ Siegmund, W.¹⁰

104
- 0033753435
- Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: A new type of drug/drug interaction
- 11061574 1:CAS:528:DC%2BD3cXot1Wjsbg%3D 10.1067/mcp.2000.109797
- K. Westphal A. Weinbrenner M. Zschiesche G. Franke M. Knoke R. Oertel P. Fritz O. von Richter R. Warzok T. Hachenberg H. M. Kauffmann D. Schrenk B. Terhaag H. K. Kroemer W. Siegmund 2000 Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction Clin. Pharmacol. Ther. 68 345 355 11061574 1:CAS:528:DC%2BD3cXot1Wjsbg%3D 10.1067/mcp.2000.109797
- (2000) Clin. Pharmacol. Ther. , vol.68 , pp. 345-355
- Westphal, K.¹ Weinbrenner, A.² Zschiesche, M.³ Franke, G.⁴ Knoke, M.⁵ Oertel, R.⁶ Fritz, P.⁷ Von Richter, O.⁸ Warzok, R.⁹ Hachenberg, T.¹⁰ Kauffmann, H.M.¹¹ Schrenk, D.¹² Terhaag, B.¹³ Kroemer, H.K.¹⁴ Siegmund, W.¹⁵

105
- 0030807293
- LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients- A controlled 6-week clinical trial
- 9342764 1:CAS:528:DyaK2sXntlyhsrw%3D 10.1055/s-2007-979523
- D. Wheatley 1997 LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients- a controlled 6-week clinical trial Pharmacopsychiatry 30 Suppl2 77 80 9342764 1:CAS:528: DyaK2sXntlyhsrw%3D 10.1055/s-2007-979523
- (1997) Pharmacopsychiatry , vol.30 , Issue.SUPPL.2 , pp. 77-80
- Wheatley, D.¹

106
- 17644380257
- Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
- DOI 10.1007/s11095-004-9004-4
- C. Y. Wu L. Z. Benet 2005 Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system Pharm. Res. 22 11 23 15771225 1:CAS:528:DC%2BD2MXhtlCks70%3D 10.1007/s11095-004-9004-4 (Pubitemid 40558141)
- (2005) Pharmaceutical Research , vol.22 , Issue.1 , pp. 11-23
- Wu, C.-Y.¹ Benet, L.Z.²

107
- 71949087143
- Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: Challenges in predicting drug interactions
- 19839641 1:CAS:528:DC%2BD1MXhtl2qurjF 10.1021/mp900132e
- L. Zhang Y. Zhang S. M. Huang 2009 Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions Mol. Pharm. 6 1766 1774 19839641 1:CAS:528:DC%2BD1MXhtl2qurjF 10.1021/mp900132e
- (2009) Mol. Pharm. , vol.6 , pp. 1766-1774
- Zhang, L.¹ Zhang, Y.² Huang, S.M.³

108
- 77949351406
- Drug interactions evaluation: An integrated part of risk assessment of therapeutics
- 20045016 1:CAS:528:DC%2BC3cXit1Ogt7w%3D 10.1016/j.taap.2009.12.016
- L. Zhang K. S. Reynolds P. Zhao S. M. Huang 2010 Drug interactions evaluation: an integrated part of risk assessment of therapeutics Toxicol. Appl. Pharmacol. 243 134 145 20045016 1:CAS:528:DC%2BC3cXit1Ogt7w%3D 10.1016/j.taap.2009.12.016
- (2010) Toxicol. Appl. Pharmacol. , vol.243 , pp. 134-145
- Zhang, L.¹ Reynolds, K.S.² Zhao, P.³ Huang, S.M.⁴

109
- 0035054725
- The gut as a barrier to drug absorption: Combined role of cytochrome P450 3A and P-glycoprotein
- Y. Zhang L. Z. Benet 2001 The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein Clin. Pharmacokinet. 40 159 168 11327196 1:CAS:528:DC%2BD3MXjsVWmtrs%3D 10.2165/00003088-200140030-00002 (Pubitemid 32324448)
- (2001) Clinical Pharmacokinetics , vol.40 , Issue.3 , pp. 159-168
- Zhang, Y.¹ Benet, L.Z.²

110
- 1642360726
- Herbal Modulation of P-Glycoprotein
- DOI 10.1081/DMR-120028427
- S. Zhou L. Y. Lim B. Chowbay 2004 Herbal modulation of P-glycoprotein Drug Metab. Rev. 36 57 104 15072439 1:CAS:528:DC%2BD2cXhsl2nsbs%3D 10.1081/DMR-120028427 (Pubitemid 38387835)
- (2004) Drug Metabolism Reviews , vol.36 , Issue.1 , pp. 57-104
- Zhou, S.¹ Lim, L.Y.² Chowbay, B.³

111
- 47349110179
- Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
- 18668431 1:CAS:528:DC%2BD1cXpt1SnurY%3D 10.1080/00498250701867889
- S. F. Zhou 2008 Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition Xenobiotica 38 802 832 18668431 1:CAS:528:DC%2BD1cXpt1SnurY%3D 10.1080/00498250701867889
- (2008) Xenobiotica , vol.38 , pp. 802-832
- Zhou, S.F.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.